Please login to the form below

Not currently logged in
Email:
Password:

Ian Read

This page shows the latest Ian Read news and features for those working in and with pharma, biotech and healthcare.

Ex-FDA chief Gottlieb's quick move to pharma raises eyebrows

Ex-FDA chief Gottlieb's quick move to pharma raises eyebrows

We are fortunate to have D. Gottlieb join Pfizer’s Board of Directors,” said Pfizer executive chairman and former CEO Ian Read.

Latest news

More from news
Approximately 1 fully matching, plus 54 partially matching documents found.

Latest Intelligence

  • The Orkambi blame game The Orkambi blame game

    CEO Ian Read and AstraZeneca’s Pascal Soriot about the former’s hostile takeover bid in 2014 being the only similar example from recent history.

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Bourla was revealed as CEO in early October, after current boss Ian Read announced he would step down from the role after eight years of service. ... Bourla said: “We are at a pivotal moment in Pfizer’s history, with Ian Read having positioned the

  • Pharma deals continue to slide Pharma deals continue to slide

    At the beginning of the month this was confirmed by Ian Read, CEO of Pfizer. ... During the second quarter earnings call Read said: “We look at BD (business development) as a way of improving returns for shareholders.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Pfizer names Albert Bourla as COO Pfizer names Albert Bourla as COO

    vaccines. Ian Read, chairman and CEO, Pfizer, said: “Albert is a proven and trusted leader with over two decades of leadership experience and a demonstrated track record for delivering strong business

  • Pfizer strengthens board of directors Pfizer strengthens board of directors

    Ian Read, Pfizer's chairman and chief executive officer, said: “We are pleased to welcome Ron Blaylock to Pfizer's board of directors.

  • IFPMA appoints director general IFPMA appoints director general

    Ian Read, IFPMA's president and chief executive and chairman of Pfizer, said: “Thomas has extensive experience in the research-based biopharmaceutical industry and a deep understanding of what is needed

  • IFPMA elects Pfizer’s Ian Read as president IFPMA elects Pfizer’s Ian Read as president

    Read succeeds Merck KGaA’s Dr Stefan Oschmann for a two-year term. ... The International Federation of Pharmaceutical Manufacturers &Associations (IFPMA) has elected Pfizer's Ian Read as its new president, succeeding Merck KGaA's Dr Stefan Oschmann.

  • Adobe CEO joins Pfizer board Adobe CEO joins Pfizer board

    The addition of Shantanu Narayen to our board helps ensure that Pfizer will continue to benefit from a diversity of experience,” said Ian Read, Pfizer's chairman and CEO.

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics